Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis

BACKGROUND: Allergen immunotherapy (AIT) is an approved treatment for seasonal respiratory allergic diseases. A depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy (SCIT) has been demonstrated to be efficacious and safe in patients allergic to birch pollen and its ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Natalija, Worm, Margitta, Staubach, Petra, Jutel, Marek, Sager, Angelika, Pfaar, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533217/
https://www.ncbi.nlm.nih.gov/pubmed/36225264
http://dx.doi.org/10.1002/clt2.12185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533217/
https://www.ncbi.nlm.nih.gov/pubmed/36225264
http://dx.doi.org/10.1002/clt2.12185

Ejemplares similares